CAITLYN SMITH: Open Payments
NPI 1124613393 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 47 payments from 20 companies in 2025. Trend: 2023 $972 · 2024 $1,397 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $212 |
| Novo Nordisk Inc | 9 | $150 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Corcept Therapeutics | 1 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| PFIZER INC. | 1 | $24 |
Products named: Rybelsus, Auvelity, BOTOX, VRAYLAR, TRINTELLIX, FARXIGA, Ozempic, TZIELD.
Industry payments across GA — which companies pay providers there.
